| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-08 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-07 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-07 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-07 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |